Literature DB >> 29936532

Association Between Population Density and Genetic Risk for Schizophrenia.

Lucía Colodro-Conde1, Baptiste Couvy-Duchesne1,2,3, John B Whitfield1, Fabian Streit4, Scott Gordon1, Kathryn E Kemper3, Loic Yengo3, Zhili Zheng3, Maciej Trzaskowski3, Eveline L de Zeeuw5,6, Michel G Nivard5,6, Marjolijn Das7,8, Rachel E Neale1, Stuart MacGregor1, Catherine M Olsen1, David C Whiteman1, Dorret I Boomsma5,6, Jian Yang2,3, Marcella Rietschel4, John J McGrath2,9,10, Sarah E Medland1, Nicholas G Martin1.   

Abstract

Importance: Urban life has been proposed as an environmental risk factor accounting for the increased prevalence of schizophrenia in urban areas. An alternative hypothesis is that individuals with increased genetic risk tend to live in urban/dense areas. Objective: To assess whether adults with higher genetic risk for schizophrenia have an increased probability to live in more populated areas than those with lower risk. Design, Setting, and Participants: Four large, cross-sectional samples of genotyped individuals of European ancestry older than 18 years with known addresses in Australia, the United Kingdom, and the Netherlands were included in the analysis. Data were based on the postcode of residence at the time of last contact with the participants. Community-based samples who took part in studies conducted by the Queensland Institute for Medical Research Berghofer Medical Research Institute (QIMR), UK Biobank (UKB), Netherlands Twin Register (NTR), or QSkin Sun and Health Study (QSKIN) were included. Genome-wide association analysis and mendelian randomization (MR) were included. The study was conducted between 2016 and 2018. Exposures: Polygenic risk scores for schizophrenia derived from genetic data (genetic risk is independently measured from the occurrence of the disease). Socioeconomic status of the area was included as a moderator in some of the models. Main Outcomes and Measures: Population density of the place of residence of the participants determined from census data. Remoteness and socioeconomic status of the area were also tested.
Results: The QIMR participants (15 544; 10 197 [65.6%] women; mean [SD] age, 54.4 [13.2] years) living in more densely populated areas (people per square kilometer) had a higher genetic loading for schizophrenia (r2 = 0.12%; P = 5.69 × 10-5), a result that was replicated across all 3 other cohorts (UKB: 345 246; 187 469 [54.3%] women; age, 65.7 [8.0] years; NTR: 11 212; 6727 [60.0%] women; age, 48.6 [17.5] years; and QSKIN: 15 726; 8602 [54.7%] women; age, 57.0 [7.9] years). This genetic association could account for 1.7% (95% CI, 0.8%-3.2%) of the schizophrenia risk. Estimates from MR analyses performed in the UKB sample were significant (b = 0.049; P = 3.7 × 10-7 using GSMR), suggesting that the genetic liability to schizophrenia may have a causal association with the tendency to live in urbanized locations. Conclusions and Relevance: The results of this study appear to support the hypothesis that individuals with increased genetic risk tend to live in urban/dense areas and suggest the need to refine the social stress model for schizophrenia by including genetics as well as possible gene-environment interactions.

Entities:  

Mesh:

Year:  2018        PMID: 29936532      PMCID: PMC6142911          DOI: 10.1001/jamapsychiatry.2018.1581

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  42 in total

1.  Variance components models for gene-environment interaction in twin analysis.

Authors:  Shaun Purcell
Journal:  Twin Res       Date:  2002-12

2.  Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk.

Authors:  C B Pedersen; P B Mortensen
Journal:  Arch Gen Psychiatry       Date:  2001-11

3.  Are the cause(s) responsible for urban-rural differences in schizophrenia risk rooted in families or in individuals?

Authors:  Carsten B Pedersen; Preben Bo Mortensen
Journal:  Am J Epidemiol       Date:  2006-05-04       Impact factor: 4.897

4.  Advantages and pitfalls in the application of mixed-model association methods.

Authors:  Jian Yang; Noah A Zaitlen; Michael E Goddard; Peter M Visscher; Alkes L Price
Journal:  Nat Genet       Date:  2014-02       Impact factor: 38.330

Review 5.  Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality.

Authors:  David M Evans; George Davey Smith
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

6.  UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.

Authors:  Cathie Sudlow; John Gallacher; Naomi Allen; Valerie Beral; Paul Burton; John Danesh; Paul Downey; Paul Elliott; Jane Green; Martin Landray; Bette Liu; Paul Matthews; Giok Ong; Jill Pell; Alan Silman; Alan Young; Tim Sprosen; Tim Peakman; Rory Collins
Journal:  PLoS Med       Date:  2015-03-31       Impact factor: 11.069

7.  RAREMETAL: fast and powerful meta-analysis for rare variants.

Authors:  Shuang Feng; Dajiang Liu; Xiaowei Zhan; Mary Kate Wing; Gonçalo R Abecasis
Journal:  Bioinformatics       Date:  2014-06-03       Impact factor: 6.937

8.  Assessment of health care, hospital admissions, and mortality by ethnicity: population-based cohort study of health-system performance in Scotland.

Authors:  Srinivasa Vittal Katikireddi; Genevieve Cezard; Raj S Bhopal; Linda Williams; Anne Douglas; Andrew Millard; Markus Steiner; Duncan Buchanan; Aziz Sheikh; Laurence Gruer
Journal:  Lancet Public Health       Date:  2018-04-21

9.  Schizophrenia and subsequent neighborhood deprivation: revisiting the social drift hypothesis using population, twin and molecular genetic data.

Authors:  A Sariaslan; S Fazel; B M D'Onofrio; N Långström; H Larsson; S E Bergen; R Kuja-Halkola; P Lichtenstein
Journal:  Transl Psychiatry       Date:  2016-05-03       Impact factor: 6.222

10.  Causal associations between risk factors and common diseases inferred from GWAS summary data.

Authors:  Zhihong Zhu; Zhili Zheng; Futao Zhang; Yang Wu; Maciej Trzaskowski; Robert Maier; Matthew R Robinson; John J McGrath; Peter M Visscher; Naomi R Wray; Jian Yang
Journal:  Nat Commun       Date:  2018-01-15       Impact factor: 14.919

View more
  23 in total

1.  Toward High Reproducibility and Accountable Heterogeneity in Schizophrenia Research.

Authors:  Peter Kochunov; Paul M Thompson; L Elliot Hong
Journal:  JAMA Psychiatry       Date:  2019-07-01       Impact factor: 21.596

Review 2.  [Does the city make us ill? The effect of urban stress on emotions, behavior, and mental health].

Authors:  Mazda Adli; Jonas Schöndorf
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-08       Impact factor: 1.513

3.  Adolescent residential mobility, genetic liability and risk of schizophrenia, bipolar disorder and major depression.

Authors:  Diana Paksarian; Betina B Trabjerg; Kathleen R Merikangas; Ole Mors; Anders D Børglum; David M Hougaard; Merete Nordentoft; Thomas Werge; Carsten B Pedersen; Preben B Mortensen; Esben Agerbo; Henriette Thisted Horsdal
Journal:  Br J Psychiatry       Date:  2020-07       Impact factor: 9.319

4.  Economic hardship and mental health complaints during COVID-19.

Authors:  Dirk Witteveen; Eva Velthorst
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-12       Impact factor: 11.205

5.  Nature, Nurture, and the Polygenic Risk Score for Schizophrenia.

Authors:  Robin M Murray; Evangelos Vassos
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

6.  Brain-wide versus genome-wide vulnerability biomarkers for severe mental illnesses.

Authors:  Peter Kochunov; Yizhou Ma; Kathryn S Hatch; Neda Jahanshad; Paul M Thompson; Bhim M Adhikari; Heather Bruce; Andrew Van der Vaart; Eric L Goldwaser; Aris Sotiras; Mark D Kvarta; Tianzhou Ma; Shuo Chen; Thomas E Nichols; L Elliot Hong
Journal:  Hum Brain Mapp       Date:  2022-08-30       Impact factor: 5.399

7.  The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control Programme.

Authors:  Charlotte Gayer-Anderson; Hannah E Jongsma; Marta Di Forti; Diego Quattrone; Eva Velthorst; Lieuwe de Haan; Jean-Paul Selten; Andrei Szöke; Pierre-Michel Llorca; Andrea Tortelli; Celso Arango; Julio Bobes; Miguel Bernardo; Julio Sanjuán; José Luis Santos; Manuel Arrojo; Mara Parellada; Ilaria Tarricone; Domenico Berardi; Mirella Ruggeri; Antonio Lasalvia; Laura Ferraro; Caterina La Cascia; Daniele La Barbera; Paulo Rossi Menezes; Cristina Marta Del-Ben; Bart P Rutten; Jim van Os; Peter B Jones; Robin M Murray; James B Kirkbride; Craig Morgan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-01-23       Impact factor: 4.328

8.  The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings From the Multinational EU-GEI Study.

Authors:  Baptiste Pignon; Mohamed Lajnef; James B Kirkbride; Hugo Peyre; Aziz Ferchiou; Jean-Romain Richard; Grégoire Baudin; Sarah Tosato; Hannah Jongsma; Lieuwe de Haan; Ilaria Tarricone; Miguel Bernardo; Eva Velthorst; Mauro Braca; Celso Arango; Manuel Arrojo; Julio Bobes; Cristina Marta Del-Ben; Marta Di Forti; Charlotte Gayer-Anderson; Peter B Jones; Caterina La Cascia; Antonio Lasalvia; Paulo Rossi Menezes; Diego Quattrone; Julio Sanjuán; Jean-Paul Selten; Andrea Tortelli; Pierre-Michel Llorca; Jim van Os; Bart P F Rutten; Robin M Murray; Craig Morgan; Marion Leboyer; Andrei Szöke; Franck Schürhoff
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

9.  Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.

Authors:  Hairong He; Qingqing Liu; Ning Li; Liyang Guo; Fengjie Gao; Ling Bai; Fan Gao; Jun Lyu
Journal:  Epidemiol Psychiatr Sci       Date:  2020-01-13       Impact factor: 6.892

10.  Association between genetic and socioenvironmental risk for schizophrenia during upbringing in a UK longitudinal cohort.

Authors:  J B Newbury; L Arseneault; A Caspi; T E Moffitt; C L Odgers; D W Belsky; K Sugden; B Williams; A P Ambler; T Matthews; H L Fisher
Journal:  Psychol Med       Date:  2020-09-25       Impact factor: 10.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.